Quality of Life in Children Treated for Cancer

Lymphoma Clinical Trial

Official title: Assessment of Health/Quality of Life in Survivors of Childhood Cancer

Status Completed

Clinical Trial Summary

RATIONALE: Questionnaires that measure quality of life may improve the ability to plan treatment for children with cancer.

PURPOSE: This randomized clinical trial is studying the quality of life in children treated for cancer.

Clinical Trial Description

OBJECTIVES: I. Assess the validity and reliability of a quality of life questionnaire (MM-QOL) that is being developed for patients with previously or currently treated childhood cancers.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to age (8-12 vs 13-20) and treatment (current vs previous). Patients are randomized to one of two arms of the study. Arm I (Reliability): Patients will complete the same questionnaire two weeks apart. (age 13-20 stratum closed as of 7/14/00) Arm II (Validity): Patients will complete a study questionnaire plus a Child Health Questionnaire. Patients between ages 8-12 are interviewed and patients between ages 13-20 complete a written questionnaire.

PROJECTED ACCRUAL: A total of 716 patients (416 for arm I (208 for 8-12 age group and 208 for 13-20 age group) and 300 for arm II (150 for 8-12 age group and 150 for 13-20 age group)) will be accrued for this study. ;

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Leukemia
• Lymphoma
• Unspecified Childhood Solid Tumor, Protocol Specific

• NCT number: NCT00005881
• Study type: Observational
• Source: Children's Oncology Group
• Status: Completed
• Phase: N/A
• Start date: April 2000
• Completion date: September 2006